These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35130717)

  • 1. Sex Differences in Short-Term and Long-Term Outcomes Among Patients With Acute Ischemic Stroke in China.
    Wang M; Wang CJ; Gu HQ; Meng X; Jiang Y; Yang X; Zhang J; Xiong YY; Zhao XQ; Liu LP; Wang YL; Wang YJ; Li ZX
    Stroke; 2022 Jul; 53(7):2268-2275. PubMed ID: 35130717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in short-term outcomes after acute ischemic stroke: the fukuoka stroke registry.
    Irie F; Kamouchi M; Hata J; Matsuo R; Wakisaka Y; Kuroda J; Ago T; Kitazono T;
    Stroke; 2015 Feb; 46(2):471-6. PubMed ID: 25550372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex disparity in stroke outcomes in a multicenter prospective stroke registry in Vietnam.
    Ton MD; Dao PV; Nguyen DT; Nguyen TH; Tran CC; Duong HQ; Nguyen HN; Nguyen SH; Bui HT; Dang DP; Dao NT; Bui HTT; Hoang HB; Vo KH; Nguyen CD; Pham TQ; Nguyen TN
    Int J Stroke; 2023 Oct; 18(9):1102-1111. PubMed ID: 37190749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Female Stroke: Sex Differences in Acute Treatment and Early Outcomes of Acute Ischemic Stroke.
    Bonkhoff AK; Karch A; Weber R; Wellmann J; Berger K
    Stroke; 2021 Jan; 52(2):406-415. PubMed ID: 33493053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
    Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-Hospital Outcomes and Recurrence of Acute Ischemic Stroke in Patients With Solid Organ Malignancy.
    Garg A; Chopra S; Starr M; Rocha M; Dawod J; Leira E; Shaban A
    Neurology; 2022 Jul; 99(4):e393-e401. PubMed ID: 35487697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in Outcome After Thrombectomy for Acute Ischemic Stroke are Explained by Confounding Factors.
    Deb-Chatterji M; Schlemm E; Flottmann F; Meyer L; Alegiani A; Brekenfeld C; Fiehler J; Gerloff C; Thomalla G;
    Clin Neuroradiol; 2021 Dec; 31(4):1101-1109. PubMed ID: 33346850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sex differences on prognosis of intravenous thrombolysis: data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
    Zhou H; Chen W; Pan Y; Suo Y; Meng X; Li H; Wang Y
    Stroke Vasc Neurol; 2021 Mar; 6(1):10-15. PubMed ID: 32641445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in Long-Term Functional Decline after Ischemic Stroke: A Longitudinal Observational Study from the Fukuoka Stroke Registry.
    Irie F; Matsuo R; Nakamura K; Wakisaka Y; Ago T; Kitazono T; Kamouchi M;
    Cerebrovasc Dis; 2023; 52(4):409-416. PubMed ID: 36754022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study.
    Wang X; Li X; Xu Y; Li R; Yang Q; Zhao Y; Wang F; Sheng B; Wang R; Chen S; Wang L; Shen L; Hou X; Cui Y; Wang D; Peng B; Anderson CS; Chen H;
    Stroke Vasc Neurol; 2021 Dec; 6(4):603-609. PubMed ID: 33903179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Age and Sex on Clinical Outcome after Intravenous Recombinant Tissue Plasminogen Activator Treatment in Patients with Acute Ischemic Stroke.
    Buijs JE; Uyttenboogaart M; Brouns R; de Keyser J; Kamphuisen PW; Luijckx GJ
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):312-6. PubMed ID: 26527412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Pulse Pressure After Acute Ischemic Stroke is Associated With Unfavorable Outcomes: The Taiwan Stroke Registry.
    Tang SC; Yin JH; Liu CH; Sun MH; Lee JT; Sun Y; Hsu CS; Sun MC; Lin CH; Chen CH; Lien LM; Muo CH; Jeng JS; Hsu CY;
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28642220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular Thrombectomy in Young Patients With Stroke: A MR CLEAN Registry Study.
    Brouwer J; Smaal JA; Emmer BJ; de Ridder IR; van den Wijngaard IR; de Leeuw FE; Hofmeijer J; van Zwam WH; Martens JM; Roos YBWEM; Majoie CB; van Oostenbrugge RJ; Coutinho JM;
    Stroke; 2022 Jan; 53(1):34-42. PubMed ID: 34872339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke.
    Elkind MS; Prabhakaran S; Pittman J; Koroshetz W; Jacoby M; Johnston KC;
    Neurology; 2007 Mar; 68(11):842-8. PubMed ID: 17353472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
    Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
    Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial.
    Schellinger PD; Alexandrov AV; Barreto AD; Demchuk AM; Tsivgoulis G; Kohrmann M; Alleman J; Howard V; Howard G; Alexandrov AW; Brandt G; Molina CA;
    Int J Stroke; 2015 Oct; 10(7):1141-8. PubMed ID: 26120902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of high-sensitivity cardiac troponin T at admission is associated with increased 3-month mortality in acute ischemic stroke patients treated with thrombolysis.
    Sui Y; Liu T; Luo J; Xu B; Zheng L; Zhao W; Guan Q; Ren L; Dong C; Xiao Y; Qin X; Zhang Y
    Clin Cardiol; 2019 Oct; 42(10):881-888. PubMed ID: 31334875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Prognostic Significance of Malnutrition Risk in Patients With Acute Ischemic Stroke: Results From the Third China National Stroke Registry.
    Zhang G; Pan Y; Zhang R; Wang M; Meng X; Li Z; Li H; Wang Y; Zhao X; Liu G; Wang Y
    Stroke; 2022 Jan; 53(1):111-119. PubMed ID: 34645284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.